Source: ALL
| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.360 | None | 1.000 | 6 | 4 | 1995 | 2009 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 1998 | 2003 | ||||||||
|
POU class 4 homeobox 1 | 0.628 | 0.500 | 0.89 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 1998 | 2010 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
pyridoxal phosphatase | 0.533 | 0.731 | 0.26 |
|
disease | 0.100 | None | 0.938 | 16 | 0 | 1993 | 2017 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2007 | 2017 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1995 | 2010 | ||||||||
|
cell adhesion molecule 1 | 0.491 | 0.769 | 0.66 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2008 | 2018 | ||||||||
|
mal, T cell differentiation protein | 0.570 | 0.577 | 0.83 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2009 | 2018 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2014 | ||||||||
|
paired box 1 | 0.593 | 0.654 | 0.70 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2016 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2012 | ||||||||
|
cytochrome P450 family 2 subfamily B member 6 | 0.428 | 0.846 | 1.9E-10 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1997 | 1999 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2012 | ||||||||
|
SRY-box transcription factor 1 | 0.617 | 0.692 | 0.62 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2014 | ||||||||
|
microRNA 124-2 | 0.716 | 0.269 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2019 | |||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2008 | ||||||||
|
RNA binding motif protein 45 | 0.383 | 0.846 | 2.1E-10 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2012 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | |||||||||
|
cellular inhibitor of PP2A | 0.524 | 0.808 | 1.4E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.556 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
RAD21 cohesin complex component | 0.528 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |